Home Blog Page 1915

YAKULT SINGAPORE LAUNCHES Y1000: ITS MOST CONCENTRATED PROBIOTIC DRINK

Widely popular in Japan, Yakult’s Y1000 expands its range in Singapore to support better gut health 

SINGAPORE, Oct. 10, 2025 /PRNewswire/ — Yakult Singapore, well-loved for its premium probiotic cultured drinks, has introduced Y1000, its most concentrated probiotic drink to date. Containing over 100 billion live probiotics per bottle, Y1000 expands Yakult’s probiotic range in Singapore to support a healthy gut.

Alongside Yakult Ace Light® and Yakult Gold®, Y1000 reinforces the brand’s long-standing commitment to science-backed innovation, helping Singaporeans of all ages enjoy healthier lifestyles. Y1000 has also received international recognition, winning the Food Category Gold Award at the DIME Trend Awards and the X Trend Award in 2022, underscoring the product’s popularity among Japanese consumers.

First introduced in Japan, Y1000 is part of the Yakult 1000 series[1], which has been selling 3 million bottles a day in Japan. The health benefits of Y1000 build on 90 years of extensive probiotic research and contain Yakult’s unique Lacticaseibacillus paracasei strain Shirota™ (LcS), a probiotic strain specially cultivated to survive digestion and reach the intestines alive. There, it supports the growth of beneficial bacteria, reduces harmful bacteria, aids in digestion, and helps maintain a healthy digestive system.

Keeping a balanced and healthy gut is essential for overall wellbeing and vitality. It not only supports proper nutrient absorption and the production of neurotransmitters like serotonin, which influence our energy and mood, but also boosts the body’s natural defences to better handle stress, irregular sleep, and busy days. Good gut health can also reduce the risk of conditions such as irritable bowel syndrome (IBS), which affects one in five Singaporeans.

“Singaporeans have trusted Yakult since 1979. This year, as the nation celebrates SG60 and the Yakult brand marks 90 years of heritage, we are proud to continue this journey with the launch of Y1000 in Singapore – our most concentrated probiotic drink yet. Imported directly from Japan. It offers Singaporeans more ways to enjoy Yakult daily, with the same science and quality they trust,” said Sunami Masaaki, Managing Director, Yakult Singapore.

With the introduction of Y1000, Yakult now offers Singaporeans an expanded range of probiotic choices:

  • Yakult Ace Light®: A lighter version of Yakult with 30 billion LcS per bottle, 30% fewer calories, and sweetened with Stevia. With zero calories, it is ideal for those who prefer a lighter taste and more probiotic support for their digestive system.
  • Yakult Gold®: Formulated with less sugar and fortified with vitamin D, it contains 10 billion LcS per bottle and was awarded the Healthier Choice Symbol.
  • Y1000: Containing over 100 billion LcS per bottle, it is Yakult’s most concentrated probiotic drink to date.

From 1 October 2025, Y1000 will be available individually in selected FairPrice supermarkets and Japanese supermarkets such as Isetan Scotts and MEIDI-YA at Millenia Walk and Great World City, at S$3.50 per bottle.

About Yakult

Yakult was first introduced to Singaporeans in 1979 with the incorporation of Yakult Singapore in 1978. Although Yakult Singapore started humbly in three containers at Hillview Avenue, it operates today from a multi-million dollar ultra-modern plant at Senoko Avenue. As Yakult is produced daily, our customers can be assured of the highest quality and freshness of Yakult sold in Singapore. Yakult Singapore perseveres to continue its healthy journey to spread to all people in Singapore the benefits of its unique probiotic, L. paracasei strain Shirota, along with the principles of Shirota-ism.

Strategic Dialogues, Global Insights: SIEW 2025 Sets the Stage for Energy Transformation

SINGAPORE, Oct. 10, 2025 /PRNewswire/ — Dr Tan See Leng, Minister for Manpower and Minister-in-charge of Energy and Science & Technology will deliver the Singapore Energy Lecture at the 18th Singapore International Energy Week (SIEW) on 27 October 2025. Building on the theme “Envisioning Energy Tomorrow, Building Systems Today”, SIEW 2025 will convene global energy ministers, heads of international organisations, and industry experts to shape innovative and bold solutions for the world’s energy transition and strengthen systems for the future. 

In the spotlight at SIEW 2025

2. SG60@SIEW Energy Showcase: The Energy Showcase will envision Singapore’s energy journey towards 2065, as the country decarbonises the power sector. The Energy Showcase offers an immersive experience that brings to life how innovation, technology, and collaboration are shaping our energy future. From solar power and regional grids to energy storage systems, nuclear energy, digitalisation, and low-carbon solutions, visitors will discover Singapore’s efforts in building a secure, sustainable, and resilient energy ecosystem. The Energy Showcase will feature exhibits depicting how Singapore is powering the impossible, turning ambition into action for a cleaner, brighter energy future for generations to come.

3. SIEW Associate Events: Premiering at SIEW 2025, the ASEAN–France Forum will draw on Europe’s experience in regional interconnectivity to strengthen reliable and sustainable electricity networks in Southeast Asia. The Singapore–Sweden Forum will also showcase innovations in hydrogen, clean fuels, smart grids, energy efficiency, and startup-driven solutions. Returning for the second year, the Singapore–US Forum will explore the role of nuclear energy in shaping Southeast Asia’s clean, secure, and affordable energy future.

4. SIEW Energy Insights and Techtables: Global energy experts will gather at the SIEW Energy Insights and TechTable to explore breakthrough ideas impacting Asia’s energy future. Discussion topics include regional interconnectivity, smart grids and artificial intelligence, energy financing, carbon capture and storage, nuclear energy, and biomethane. 

5. SIEW Thinktank Roundtables: The roundtables will build open, in-depth discussions on various energy topics, co-hosted with the World Nuclear Association (WNA), the ASEAN Centre for Energy (ACE), and the Energy Studies Institute (ESI):

I. Roundtable A – Asia’s Energy Future: Building a Diverse and Resilient System: Explores strategies to enhance energy diversity and resilience across the region.
II. Roundtable B – The Evolving Role of Nuclear in the Future Energy System: Examines nuclear energy’s potential to support sustainable and secure energy systems.
III. Roundtable C – The AI-Energy Nexus: Transforming the Transition to Low-Carbon Power: Discusses how artificial intelligence can accelerate the shift to a low-carbon future.

6. Co-located Events: The third edition of the ASEAN Energy Regulatory Forum will form part of the Conference of the Electric Power Supply Industry (CEPSI). The forum will facilitate discussions on regulatory best practices, policy planning, energy markets, and regional interconnectivity. SIEW Partner events, including Asia Clean Energy Summit , Asia Gas Markets Conference, Asian Downstream Summit (ADS) | Asian Refining Technology Conference (ARTC) | Ammonia & Carbon Capture Asia (ACCA) and CEPSI will also continue to showcase innovations, foster collaboration, and provide a comprehensive platform for advancing regional energy transition.

7. SIEW 2025 will host a distinguished gathering of global leaders including: 

Governments and International Organisations

  1. H.E. Dr Tan See Leng, Minister for Manpower and Minister-in-Charge of Energy and Science & Technology, Republic of Singapore
  2. H.E. Indranee Rajah, Minister, Prime Minister’s Office, Leader of the House, Second Minister for Finance and Second Minister for National Development, Republic of Singapore
  3. H.E. Gan Siow Huang, Minister of State, Ministry of Foreign Affairs & Ministry of Trade and Industry, Republic of Singapore
  4. H.E. Ebba Busch, Deputy Prime Minister and Minister for Energy, Business and Industry, Kingdom of Sweden
  5. H.E. Sharon Garin, Secretary of Energy, Republic of the Philippines
  6. Hon Stephen Dawson MLC, Minister for Regional Development; Ports; Science and Innovation; Medical Research; and Kimberley region, Western Australia
  7. Yang Mulia Dato Seri Paduka Awang Haji Mohamad Azmi Bin Haji Mohd Hanifah, Deputy Minister (Energy), Prime Minister’s Office, Brunei Darussalam
  8. The Right Honourable Datuk Patinggi Tan Sri (Dr) Abang Haji Abdul Rahman Zohari bin Tun Datuk Abang Haji Openg, Premier of Sarawak, Sarawak Government
  9. H.E. Shri Shripad Yesso Naik, Minister of State of the Ministry of Power; Ministry of New and Renewable Energy, Government of India
  10. H.E. Eddy Soeparno, People’s Consultative Assembly Vice Speaker, Republic of Indonesia
  11. H.E. Chanthaneth Bualapha, Vice Minister of Agriculture and Environment, Lao PDR
  12. H.E. Felix William B. Fuentebella Undersecretary of Energy, Republic of the Philippines
  13. Dr Anders Hoffmann, IEA Governing Board Chair, Deputy Permanent Secretary, Ministry for Climate, Energy and Utilities, Denmark
  14. Dr Sompop Pattanariyankool, Deputy Permanent Secretary, Ministry of Energy, Kingdom of Thailand
  15. Clare McLaughlin, Australia’s Governor to the International Energy Agency, and Head of Division, Energy Performance and Security, Australia
  16. Lee Mcdonough, Director General, Net Zero, Nuclear and International, Department for Energy Security and Net Zero (DESNZ), United Kingdom
  17. Ann K. Ganzer, Principal Deputy Assistant Secretary, Bureau of Arms Control and Nonproliferation, U.S. Department of State
  18. Xin Bao‘an, Chairman, Global Energy Interconnection Development and Cooperation Organisation (GEIDCO)
  19. Dr Fatih Birol, Executive Director, International Energy Agency (IEA)
  20. Francesco La Camera, Director-General, International Renewable Energy Agency (IRENA)
  21. Lin Yang, Deputy Executive Secretary for Programme, Economic and Social Commission for Asia and the Pacific (ESCAP)
  22. Dato’ Ir. Ts. Razib Dawood, Executive Director, ASEAN Centre for Energy (ACE)
  23. Dr Jennifer T. Gordon, Director of the Nuclear Energy Policy Initiative and Daniel B. Poneman chair for nuclear energy policy Global Energy Cente, Atlantic Council
  24. Hideaki Iwasaki, Director General, Sectors Department 1 (Energy and Transport Sectors), Asian Development Bank (ADB)
  25. Dr Sama Bilbao y León, Director General, World Nuclear Association

Regulators and Utilities 

  1. Justin Oliver, Deputy Chair, Australian Energy Regulator
  2. Stéphanie Guénot-Bresson, Commissioner, Nuclear Safety and Radiation Protection Authority (ASNR) (France)
  3. Shri Ghanshyam Prasad, Chairperson, Central Electricity Authority (India)
  4. Puah Kok Keong, Chief Executive, Energy Market Authority of Singapore
  5. Tatsuya Shinkawa, Secretary General, Electricity and Gas Market Surveillance Commission (Japan)
  6. Siti Safinah binti Salleh, Chief Executive Officer, Energy Commission (Malaysia)
  7. Judy Chang, Commissioner, Federal Energy Regulatory Commission, United States
  8. Ir Raymond Ky Poon, Director, the Electrical & Mechanical Services Department, The HKSAR Government
  9. Mark McAllister, Chairman, Office of Gas and Electricity Markets (United Kingdom)
  10. Stanley Huang, Group CEO, SP Group, Singapore
  11. Datuk Ir. Megat Jalaluddin bin Megat Hassan, Chief Executive Officer, Tenaga Nasional Berhad, Malaysia

Industry 

  1. Jean-Pascal Tricoire, Chairman, Schneider Electric
  2. Wu Junli, Chairman, PetroChina International
  3. Martin Houston, Chairman, Omega Oil and Gas
  4. Tadashi Maeda, Chairman of the Board, Japan Bank for International Cooperation
  5. Andy Piepel, Vice President R&D, Electrical Markets Division, 3M
  6. Dr Owen Chen, Chief Technology Officer & Vice President, Concord New Energy Group
  7. Lim Wee Seng, Group Head of Sustainability, Energy, Renewables & Infrastructure, Project Finance and Strategic Advisory, Institutional Banking Group, DBS Bank
  8. Professor Lee Poh Seng, Executive Director, Energy Studies Institute
  9. Dominic Genetti, Senior Vice President, Carbon Capture and Storage, ExxonMobil Low Carbon Solutions
  10. Alan Heng, Chief Executive Officer, Singapore GasCo
  11. Sims Witherspoon, Climate Action Lead, Google DeepMind Institute
  12. Izumi Kai, CEO, JERA Asia, Head of Platform Business Division, JERA Co
  13. Cindy Lim, Chief Executive Officer, Infrastructure, Keppel
  14. Raphaël Barreau, Chief Investment Officer, Masdar
  15. Rajat Agarwal, Partner, McKinsey & Company
  16. Takao Tsukui, President and CEO, Mitsubishi Power
  17. Pascal Radue, Senior Executive Vice President, Power Transmission, Nexans
  18. Elaine Lam, Group Managing Director, Head of Global Corporate Banking, OCBC Bank
  19. Yu Tat Meng, Chief Executive Officer, PacificLight
  20. Detlev Waimann, SVP for the Transmission Business, Chief Commercial Officer of Transmission, Prysmian
  21. William Goh, Global Head of Renewable Energy, RGE
  22. Veronika Milewski, CEO, RTE International
  23. Thorbjörn Fors, Group Senior Vice President and Managing Director of Asia Pacific, Siemens Energy
  24. Ong Teng Koon, CEO, Singapore Energy Interconnections
  25. Leong Wei Hung, Chief Executive Officer, Singapore LNG Corporation
  26. Dr Nor Azlan Bin Mostafa, Chief Strategy & Planning Officer, Single Buyer, Malaysia
  27. Jeanne Soh, Head of Asia, Structured Finance Asia Pacific, Sumitomo Mitsui Banking Corporation
  28. Itxaso Ariza, Chief Technology Officer, Tokamak Energy
  29. Helle Kristoffersen, President Asia and Member of Executive Committee, TotalEnergies
  30. Juan Mas Valor, Chief Operating Officer, Vena Group

8. The full list of speakers attending SIEW 2025 is available here.

9. Register now at https://register.siew.gov.sg.

About SIEW

Singapore International Energy Week 2025
Singapore International Energy Week 2025

The Singapore International Energy Week (SIEW) is an official trademarked event by the Energy Market Authority (EMA). It is an annual platform for energy professionals, policymakers and commentators to discuss and share best practices and solutions within the global energy space. The 18th edition of SIEW will be held from 27–31 October 2025 in Singapore.

The SIEW logo is an officially registered trademark, a symbol of credibility and prestige as the world’s leading energy event.

About the Energy Market Authority

Energy Market Authority
Energy Market Authority

The Energy Market Authority (EMA) is a statutory board under the Singapore Ministry of Trade and Industry. Through our work, we seek to build a clean energy future that is resilient, sustainable, and competitive. We aim to ensure a reliable and secure energy supply, promote effective competition in the energy market and develop a dynamic energy sector in Singapore. Visit www.ema.gov.sg for more information.

ACROBiosystems and Partners Conclude OrganoAsia 2025

  • Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization

SEOUL, South Korea, Oct. 10, 2025 /PRNewswire/ — ACROBiosystems, together with Leica Biosystems, Molecular Devices, and Leica Microsystems, hosted the OrganoAsia 2025-The Frontier of Organoid Science in Beijing. The hybrid-format conference featured an in-person opening session alongside a live online stream, drawing more than 500 experts and researchers—primarily from China, Japan, and South Korea, with additional global attendees—to examine recent progress and future directions for organoid technology in precision medicine, drug discovery, and regenerative medicine.


Expert Perspectives: Broad-Based Progress in Research and Industrial Applications

The conference gathered leading specialists such as Rosanna Zhang, Vice President of ACROBiosystems; Li Liang, Associate Professor at the Southern University of Science and Technology (SUSTech); Professor Ki-Suk Kim of the Korean Institute of Toxicology; Associate Professor Na Jie from Tsinghua University; and Associate Professor Yoh-Ichi Tagawa from the Tokyo University of Science. They presented the latest research advances across areas including disease modeling, drug screening, and toxicology assessment.


Rosanna Zhang, Vice President of ACROBiosystems, discussed innovative uses of organoids in drug screening and toxicity testing. She noted that as global regulatory policies increasingly encourage alternatives to animal testing—guided by the 3R principles—organoid technology is transforming drug screening and safety evaluation methods by closely mimicking the human physiological microenvironment. ACROBiosystems has introduced a series of ready-to-use organoid products for the heart, brain, liver, intestine, lung, and other major organ types, along with disease modeling, and testing services. Zhang also shared that the company intends to broaden its range of organ models to aid high-throughput screening and mechanistic research for novel drug development. Through its integrated Organoid Toolbox, ACROBiosystems provides a complete solution to help researchers more effectively conduct efficacy screening, toxicity evaluation, and mechanism exploration.

Li Liang’s team at the SUSTech School of Medicine established a biobank of patient-derived organoids that accurately recapitulates organ microenvironments. During the COVID-19 pandemic, the group used a respiratory organoid platform to identify tissue tropism differences among SARS-CoV-2 variants—for example, the Delta variant caused pneumonia, while Omicron BA.2 mainly infected the upper respiratory tract. Through high-throughput screening, the team also discovered a horse-derived polyclonal antibody that later demonstrated effectiveness in neutralizing multiple variants. In addition, the researchers combined organoids with microfluidic technology to create a dual-channel “organ-on-a-chip”, which models gut–microbiome interactions by separating hypoxic and oxygen-rich channels, overcoming constraints of conventional co-culture systems. This work has been extended to studies of viral encephalitis mechanisms—such as brain injury caused by Dengue and Zika viruses—precision oncology drug screening using patient-derived tumor organoid (PDTO) models, and evaluation of inhaled vaccine delivery. The team is now scaling up efforts to automate the production of up to the scale of 10^5 organoids for transplantation, creating new opportunities for regenerative medicine.

Professor Ki-Suk Kim, Principal Researcher at the Korean Institute of Toxicology, and his colleagues focused on using stem cell–based 3D organoid models for toxicology assessment. As drug development moves toward non-animal testing worldwide, these 3D organoid systems help improve the precision and efficiency of drug safety evaluation. For cardiotoxicity testing, the team engineered heart organoids that mimic the structure and function of the human heart. By integrating multi-ion channel detection with microelectrode array (MEA) technology, they can better assess a drug’s impact on cardiac electrophysiology. In neurodevelopmental toxicity studies, the group used iPSC-derived human brain organoids to model brain development, revealing how the antipsychotic drug haloperidol impairs neurodevelopment by inhibiting the Notch1 signaling pathway. They also identified compounds that reduce this toxicity. Professor Kim stressed that organoid technology is set to become a central component of drug safety evaluation in the new era of animal-free testing, enabling more efficient and targeted drug development.

Associate Professor Na Jie’s team at Tsinghua University directed human pluripotent stem cells to differentiate into cardiomyocytes, endothelial cells, smooth muscle cells, and macrophages. Using 3D printing, they produced vascular organoids with greater maturity and improved capacity to repair ischemic tissue. Furthermore, the research team developed a co-culture system where macrophages were integrated with heart organoids, demonstrating significant improvements in cardiomyocyte maturation and contractility. This platform established a physiologically relevant model for screening cardiotoxicity risks of emerging therapeutics, such as antibody-based drugs. In parallel, they generated Vascularized and Immune cell-infiltrated Cerebral Organoids (VICO). When transplanted to ischemic stroke models, VICO promoted cerebral perfusion recovery and functional neurological outcomes. These advances offer new pathways for modeling Cardio-cerebrovascular diseases, advancing regenerative medicine, and supporting precision drug assessment.

Associate Professor Yoh-Ichi Tagawa’s group at the Institute of Science Tokyo centered its work on a microfluidic gut-on-a-chip co-culture system for modeling Inflammatory Bowel Disease (IBD). By co-culturing human intestinal epithelial cells with gut microbiota, the team recreated key aspects of the intestinal microenvironment, overcoming rapid bacterial overgrowth to achieve stable and reproducible in vitro co-culture. Using this platform, they developed an IBD induction model that revealed interactions between gut microbiota and immune cells, along with shifts in inflammatory factor expression, and confirmed the therapeutic effect of the TNF-α inhibitor TPCA-1. This gut-on-a-chip system can serve as an alternative to conventional animal testing for disease mechanism studies and drug screening, with strong potential for scaling. Professor Tagawa indicated that future efforts will aim to combine multiple organ chips into more complex human simulation systems, offering highly representative, high-throughput platforms for disease research and drug discovery.

Roundtable Discussion: Focus Turns to Standardization and Industrialization

At the roundtable forum, participants examined issues including quality control, batch-to-batch consistency, and the creation of standardization frameworks for organoid research. Experts agreed on the importance of increasing data sharing, harmonizing operational protocols, gaining regulatory acceptance for organoid models in drug development and registration, and assessing the scalability of integrated “human-on-a-chip” systems.

Looking ahead, attendees emphasized the need to move forward with organoid standardization, share data and methodologies, strengthen dialogue with regulators to facilitate the use of organoid data in drug development and approval processes, and investigate the “human-on-a-chip” concept by linking multiple organ models for consistent and reproducible testing. Experts also pointed out that generating highly mature organoids comparable to adult human tissues remains a key challenge, requiring a balanced approach between advancing technical standards and carefully selecting appropriate developmental stages.


Future Collaboration: ACROBiosystems Strengthens Asia-Pacific Ecosystem, Bridging Research and Industry

The successful OrganoAsia 2025 conference enabled ACROBiosystems to help drive international scientific cooperation, establishing a strong foundation for a collaborative network that spans organoid research, development and manufacturing. This effort supports the Asia-Pacific region’s transition toward deeper integration of organoid science and industrial use. During the event, ACROBiosystems reached multiple collaboration agreements in the organoid field with participating institutions. The company will continue to work with global partners to broaden organoid technology’s role in drug discovery, precision medicine and other advanced fields. ACROBiosystems also invites interested organizations to help grow OrganoAsia into a leading international platform for exchange and partnership.

ACROBiosystems Group

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company with a mission to support the global biopharmaceutical and healthcare industries by providing products and innovative business models. The company operates globally and maintains offices, R&D centers, and production facilities in more than 10 cities within the United States, Switzerland, the United Kingdom and Germany. ACROBiosystems Group has established long-term partnerships with the world’s top pharmaceutical firms, including Pfizer, Novartis, and Johnson & Johnson, and leading academic institutions. The company comprises several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics.

Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers its partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapies, and their clinical applications, and contributes to global health.

China’s Central Academy of Fine Arts Launches AI-Powered Chatbot to Enhance Global Website Experience

BEIJING, Oct. 10, 2025 /PRNewswire/ — The Central Academy of Fine Arts (CAFA), China’s most prestigious and renowned art academy, has introduced an AI-powered chatbot on its CAFA Global website (global.cafa.edu.cn), becoming the first art academy in China to leverage artificial intelligence for international communication. Powered by DeepSeek’s model and customized with CAFA’s own knowledge base, the chatbot is available 24/7 to assist users worldwide with information searches, admissions queries, data analysis, and more.

AI-Powered Chatbot
AI-Powered Chatbot

This move marks a further step in CAFA’s ongoing commitment to international engagement and digital innovation. The AI assistant transforms the global website from a traditional information hub into a dynamic, interactive platform, creating a more accessible experience for students, educators, and art institutions across the globe. It represents a shift from one-way information delivery to intelligent user interaction, aligning with global trends in education technology.

The CAFA Global website was first launched in October 2023 and has since served as an essential gateway for international audiences to explore CAFA’s legacy, academic strengths, and vibrant campus culture. Designed with contemporary aesthetics and user experience in mind, the platform offers content in English that spans from faculty introductions and research highlights to exhibitions, cultural exchanges, and global cooperation projects.

“The launch of our AI chatbot reflects CAFA’s forward-looking approach and marks a new step in the digital transformation of art education,” said Lin Mao, President of Central Academy of Fine Arts. “It expands global access to our diverse academic resources and demonstrates China’s growing influence in integrating technology and the arts.”

As AI technology reshapes communication, CAFA is setting a new standard for how educational institutions engage with the world. The launch of the CAFA Global AI chatbot is only the beginning of a broader effort to foster deeper cultural exchange and educational connectivity through digital means.

About the Central Academy of Fine Arts (CAFA)

The Central Academy of Fine Arts (CAFA) is China’s top fine arts institution under the Ministry of Education. With 14 specialized schools spanning painting, design, architecture, and art technology, CAFA offers programs from secondary to doctoral levels. Home to over 6,000 students and 1,000 faculty, the academy blends Chinese cultural heritage with global vision, earning international recognition for its academic excellence and innovation in art education. For more information, please visit global.cafa.edu.cn

Taiwan Fresh Pork Re-Entry Launch & Food Tasting at Kai Garden

Dear Media Friends,

You are cordially invited to a press conference and exclusive food tasting featuring premium Taiwan Fresh Pork — re-entering Singapore after 15 years.

Taiwan has been officially certified by the World Organisation for Animal Health (WOAH) as Asia’s only country free from Classical Swine Fever, Foot-and-Mouth Disease, and African Swine Fever.

Join us for a firsthand taste of this sweet, tender, and odour-free premium pork, beautifully prepared by the culinary team at Kai Garden, one of Singapore’s leading Cantonese fine dining restaurants.

Event Highlights:
Press conference & media Q&A
Gourmet food tasting of dishes prepared from Taiwan premium fresh pork
Interview with Taiwan’s Commerce Development Research Institute (CDRI) representatives.
Photo & filming opportunities

Date: Tuesday, 28th October 2025
Time:  3:30 PM – 4:30 PM
Venue: Kai Garden, 6 Raffles Blvd, #03-128A/128B Marina Square, Singapore 039594

Organized by Liverpool Food Supplier Pte Ltd

Seats are limited. Kindly RSVP by Friday, 17th October to confirm your attendance.
Your response will help us in planning and better preparation.

We look forward to welcoming you to this historic culinary comeback!

Media Contact person: Eva Lew
E-mail: pr@liverpoolfspl.com 

Contact Number: +65 89066365 (WhatsApp only).

This Taiwan Pork initiative is led by the Commerce Development Research Institute (CDRI) of Taiwan, and sponsored by Taiwan Ministry of Agriculture.

/PRNewswire — Oct. 10, 2026/

LingoAce Earns ITEFLAC Accreditation for TEFL Training, Raising Standards for Teachers and Learners Worldwide

SINGAPORE and NEW YORK, Oct. 10, 2025 /PRNewswire/ — LingoAce, a global leader in online education, today announced that its proprietary 120-hour Online TEFL (Teaching English as a Foreign Language) Certification Course has officially been accredited by the International TEFL Accreditation Council (ITEFLAC). This recognition affirms LingoAce’s commitment to raising the bar in teacher training and delivering trusted, high-quality English learning experiences for its learners.

ITEFLAC, an independent accreditation body headquartered in London, UK, is known for its rigorous evaluation system covering eight key performance areas, including teaching quality, faculty standards, curriculum design, learner support, and program management. LingoAce’s program earned top marks in critical categories such as teaching quality, learner support, and course structure, underscoring the scientific, systematic, and practical strength of its teacher training model.

“Earning ITEFLAC accreditation is more than an endorsement of our English program, it’s a promise to families and learners that every LingoAce teacher has been prepared to meet global standards,” said Hugh Yao, Founder and CEO of LingoAce. “It reflects our ongoing investment in instructional excellence and our belief that language learning should build confidence, communication skills, and global citizenship.”

Raising the Standard of Learning Outcomes for Learners

With ITEFLAC accreditation, LingoAce strengthens its promise to families: every child learns in classrooms defined by quality, care, and measurable progress.

  • World-Class Teaching: Every LingoAce teacher completes a structured, internationally accredited training program, ensuring consistent instructional quality and measurable learning outcomes for children ages 4-15.
  • Student-Centered Classrooms: Teachers are equipped with child-focused strategies that make learning interactive, engaging, and effective.
  • Global Readiness: Students gain not just language proficiency, but also critical thinking and cross-cultural communication skills that prepare them for future academic and international opportunities.
Professional Growth and Career Opportunities for Educators

For educators, the program offers more than a credential—it provides the skills, flexibility, and recognition needed to grow a sustainable teaching career in a global marketplace.

  • Professional Curriculum: A 120-hour program covering 23 modules of online teaching skills, blending theory with practice through real-world simulations and collaborative projects.
  • Flexible Learning: Designed for working professionals, requiring as little as 20 study hours per week. 100% online, accessible anytime, anywhere.
  • International Recognition: Graduates receive an internationally accredited certificate, strengthening their credentials and unlocking global ESL teaching opportunities.
  • Career Pathways with LingoAce: Top graduates are invited to join the LingoAce teaching team, gaining access to a large and diverse student base, with long-term career growth supported by the company’s global ecosystem.

Following its achievement of profitability and positive cash flow in 2024, LingoAce continues to reinvest in curriculum innovation and instructional quality. The ITEFLAC accreditation further strengthens the company’s mission to build an education ecosystem where families trust progress, teachers find empowerment, and learners grow into confident global citizens.

About LingoAce

LingoAce is a global education technology company on a mission to make learning for kids more engaging, effective, and accessible through technology. Founded in 2017, the company is headquartered in Singapore and has global operations throughout the United States, Southeast Asia, Europe, and China. Backed by the world’s top investors, including Peak XV Partners (formerly Sequoia India & Southeast Asia), Owl Ventures, Tiger Global, and Shunwei Capital, LingoAce has a roster of more than 5,000 professionally certified teachers and has taught more than 20 million classes to PreK-12 learners in more than 100 countries. In 2023, LingoAce was named to Fast Company’s World’s Most Innovative Companies list and the GSV EdTech 150 list of the world’s most transformative edtech companies for the second year in a row. In 2025, LingoAce won the EdTechX Asia Pacific Award. Learn more about LingoAce: https://www.lingoace.com/.

Faraday Factory and Zenno advance HTS magnets for space

Joint effort will boost innovative electric equipment for satellite manoeuvrability

TOKYO and AUCKLAND, New Zealand, Oct. 10, 2025 /PRNewswire/ — Faraday Factory Japan LLC, the world’s leading superconducting tape maker (Faraday Factory), and New Zealand headquartered space-flight systems company Zenno Astronautics (Zenno), a developer of world-first superconducting electromagnets for space applications, announced a new initiative to improve superconductor magnets for space applications.

Flight-readiness inspection by a Zenno technician on a superconducting magnet assembly
Flight-readiness inspection by a Zenno technician on a superconducting magnet assembly

Based on 30+ years of experience in materials science of high temperature superconductors, Faraday Factory’s team has initiated a strategic work to tailor superconductors specifically for space applications. In frame of collaboration, Faraday Factory will provide and Zenno will apply to magnet coils new types of HTS tape including new Mirai superconducting tape, which was unveiled in July 2025.

Although state-of-the-art superconductor performance already enables useful products for space environment, the development of improved superconductor wires aims to further increase operating margins, shorten uptime, decrease weight and reduce energy consumption. Space applications are especially demanding, hence the optimization effort is of paramount importance ensuring that full potential of superconductor is revealed in orbital operation.

The new collaboration will target temperature and magnetic field ranges, which are specific to game-changing Zenno’s products such as Z01 Supertorquer. Faraday Factory expects that the new, drastically improved, superconductor product for space applications will be the result of this ongoing effort.

“I look forward to testing new HTS tape of Faraday Factory. Mirai could materially boost Supertorquer performance by delivering faster response and stronger magnetic dipole in the same compact, efficient form factor – enabling greater manoeuvrability in space,” said Sebastian Wieczorek, co-founder and Chief Product Officer at Zenno Astronautics.

“Our work will demonstrate that performance of high temperature superconductor devices can be significantly boosted with the use of materials science. The efficient technical collaboration between experts of Faraday Factory and Zenno Astronautics is essential for bringing tangible results,” said Sergey Samoilenkov, Director of Strategy at Faraday Factory Japan. 

About Zenno Astronautics

Zenno Astronautics Limited is a New Zealand, Europe and US-based company pioneering the future of sustainable and safe spacecraft operations utilising a range of superconducting magnet applications. Zenno enables fully autonomous and fuel-free satellite positioning and precision interactions between satellites. Zenno is creating multiple applications of superconductivity in space, including radiation shielding, plasma control, close proximity operations and beyond, for the benefit of the entire space sector.

About Faraday Factory Japan 

Faraday Factory Japan LLC runs the largest manufacturer facility of high-temperature superconductor (HTS) tape worldwide. The company has developed a successful technology based on pulsed laser deposition. The company constantly increases its production capacity, addressing the rapidly growing demand from fusion, power grid, and other technology markets.

Zenno Supertorquer product, built with Faraday Factory HTS tape
Zenno Supertorquer product, built with Faraday Factory HTS tape

WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year

SHANGHAI, Oct. 10, 2025 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced it has received the esteemed AAA ESG rating from Morgan Stanley Capital International (MSCI) for the third consecutive year.

This top-tier rating by MSCI, a premier global data provider of ESG ratings and research, places WuXi Biologics among an elite group of companies globally recognized for outstanding ESG performance, and acknowledges the company’s strong leadership in advocating sustainability, particularly in the key areas of climate change, product safety and quality, human capital development, and corporate governance.

Covering more than 17,000 issuers and 999,000 securities worldwide, MSCI ESG Ratings provide valuable insights for investment decision-making as they focus on measuring companies’ resilience to financially relevant, industry-specific sustainability risks and opportunities.

Dr. Chris Chen, WuXi Biologics CEO and Chairman of the ESG Committee, commented, “We are deeply honored to receive an MSCI AAA rating for the third consecutive year, a recognition that validates our persistent efforts in pursuing sustainability. As a global leader in Green CRDMO, we consistently deliver ESG excellence, enable partners worldwide with end-to-end solutions, and work together with all stakeholders to drive responsible practices.”

In line with the United Nations Sustainable Development Goals, WuXi Biologics has been actively engaged with the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI). Recently, the company’s new near-term and net-zero greenhouse gas emissions-reduction target matrix has been approved by the Science Based Targets initiative (SBTi).

WuXi Biologics proactively advocates sustainability and has earned widespread recognition for its efforts. The company was awarded an EcoVadis Platinum Medal; listed in the Dow Jones Sustainability Indices (DJSI); named to the CDP Water Security “A list” and awarded an A- CDP Climate Change leadership-level score for two consecutive years; given the highest negligible-risk rating by Sustainalytics, and recognized as a Sustainalytics industry and regional ESG top-rated company for five consecutive years; selected as a Constituent of the FTSE4Good Index Series; listed in the Hang Seng ESG 50 Index; and rated as Prime by ISS ESG Corporate Rating.

DISCLAIMER STATEMENT

THE USE BY WUXI BIOLOGICS OF ANY MSCI ESG RESEARCH LLC OR ITS AFFILIATES (“MSCI”) DATA, AND THE USE OF MSCI LOGOS, TRADEMARKS, SERVICE MARKS OR INDEX NAMES HEREIN, DO NOT CONSTITUTE A SPONSORSHIP, ENDORSEMENT, RECOMMENDATION, OR PROMOTION OF WUXI BIOLOGICS BY MSCI. MSCI SERVICES AND DATA ARE THE PROPERTY OF MSCI OR ITS INFORMATION PROVIDERS, AND ARE PROVIDED ‘AS-IS’ AND WITHOUT WARRANTY. MSCI NAMES AND LOGOS ARE TRADEMARKS OR SERVICE MARKS OF MSCI.

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.

With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of June 30, 2025, WuXi Biologics is supporting 864 integrated client projects, including 24 in commercial manufacturing.

WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives green technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while consistently achieving excellence in Environment, Social and Governance (ESG). Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts and promote responsible practices that empower the entire value chain.

For more information about WuXi Biologics, please visit: www.wuxibiologics.com.

Contacts

ESG
esg@wuxibiologics.com

Media
PR@wuxibiologics.com